XML 16 R5.htm IDEA: XBRL DOCUMENT v3.8.0.1
CONDENSED CONSOLIDATED STATEMENTS OF EQUITY - USD ($)
Total
Total Stockholders’ Equity
Class T and Class I Common Stock
Additional Paid-In Capital
Accumulated Deficit
Net Income (Loss) Attributable to Redeemable Noncontrolling Interest $ 0        
Beginning balance, Shares at Dec. 31, 2016     11,377,439    
Beginning balance Stockholders' Equity, including Portion Attributable to Noncontrolling Interest at Dec. 31, 2016   $ 92,255,000 $ 114,000 $ 99,492,000 $ (7,351,000)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock, shares     7,609,328   0
Amortization of nonvested common stock compensation   14,000   14,000  
Issuance of common stock   75,615,000 $ 76,000 75,539,000  
Offering costs - common stock   (7,608,000)   (7,608,000)  
Issuance of common stock under the DRIP, shares     113,147    
Issuance of common stock under the DRIP 1,063,000 1,063,000 $ 1,000 1,062,000  
Dividends, Common Stock, Cash   (2,171,000)     $ (2,171,000)
Net Income (Loss) Attributable to Parent 85,000 (85,000)     (85,000)
Ending balance Stockholders' Equity, including Portion Attributable to Noncontrolling Interest at Mar. 31, 2017   159,083,000 $ 191,000 168,499,000 (9,607,000)
Ending balance, Shares at Mar. 31, 2017     19,099,914    
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Adjustments to Additional Paid in Capital, Fair Value Adjustment to Redeemable Noncontrolling Interests 0        
Net Income (Loss) Attributable to Redeemable Noncontrolling Interest (67,000)        
Beginning balance, Shares at Dec. 31, 2017     42,207,160    
Beginning balance Stockholders' Equity, including Portion Attributable to Noncontrolling Interest at Dec. 31, 2017 353,224,000 353,224,000 $ 422,000 376,284,000 $ (23,482,000)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock, shares     5,314,261   0
Stock Repurchased During Period, Value   (397,000) $ 0 (397,000)  
Amortization of nonvested common stock compensation   30,000   30,000  
Issuance of common stock   52,820,000 $ 53,000 52,767,000  
Offering costs - common stock   4,992,000   4,992,000  
Issuance of common stock under the DRIP, shares     383,756    
Issuance of common stock under the DRIP 3,606,000 3,606,000 $ 3,000 3,603,000  
Dividends, Common Stock, Cash   (6,686,000)     $ (6,686,000)
Net Income (Loss) Attributable to Parent 2,169,000 (2,169,000) [1]     (2,169,000)
Ending balance Stockholders' Equity, including Portion Attributable to Noncontrolling Interest at Mar. 31, 2018 395,369,000 395,369,000 $ 478,000 427,228,000 $ (32,337,000)
Ending balance, Shares at Mar. 31, 2018     47,863,989    
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Stock Repurchased During Period, Shares     (41,188)    
Adjustments to Additional Paid in Capital, Fair Value Adjustment to Redeemable Noncontrolling Interests $ 67,000 $ (67,000)   $ (67,000)  
[1] Amount excludes $(67,000) of net loss attributable to redeemable noncontrolling interests for the three months ended March 31, 2018. See Note 10, Redeemable Noncontrolling Interests, for a further discussion.